Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc0fe1f05f2d0ff3837f63ecfb79b6fe |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
1999-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2cf38ba10d3e294ea1c394e1ed70cb7 |
publicationDate |
2000-08-31^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0050583-A1 |
titleOfInvention |
Antisense modulation of g-alpha-12 expression |
abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of G-alpha-12. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding G-alpha-12. Methods of using these compounds for modulation of G-alpha-12 expression and for treatment of diseases associated with expression of G-alpha-12 are provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1784498-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1784498-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010030167-A3 |
priorityDate |
1999-02-23^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |